Life Sciences

FDA issues guidance on enterovirus nucleic acid assays

Device Regulation Alert: Safety, Compliance and Reimbursement News, January 12, 2009

Any firm that submits a 510(k) for enterovirus nucleic acid assays must show that its device addresses safety and effectiveness concerns identified in new FDA guidance.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular